The Crohn’s & Colitis Foundation of America Announces New National Board of Trustees Chair and Three New Members
New York, NY – The Crohn’s & Colitis Foundation of America (CCFA) is delighted to announce Maura C. Breen as its new National Board of Trustees Chair along with Donald Burke, John Crosson and Matt Leavitt, D.O., FAOCD as new members of the board.
“We are delighted to have Maura heading up such an esteemed group of volunteers,” said Richard Geswell, President of the Crohn’s & Colitis Foundation of America. “We are so fortunate to have an outstanding group of accomplished and passionate leaders guiding our organization. It’s a very exciting time at CCFA. Every day, we move closer and closer to our ultimate goal of a future free from Crohn’s disease and ulcerative colitis.”
Maura C. Breen
Ms. Breen brings extensive experience to her new role as CCFA’s National Board of Trustees Chair in the areas of marketing and branding, cost control and restructuring, technology and innovation, sales and business development, and operations. She worked at Verizon for 30 years where she held a variety of leadership positions including Senior Vice President and General Manager for the New York Region, Senior Vice President and Chief Marketing Officer of Verizon's Retail Markets Group and Group President of Verizon Long Distance which she helped launch. Ms. Breen began her career with New England Telephone Company, moving to NYNEX in 1990.
She has been a Director of Express Scripts Inc., a pharmaceutical benefits company based in St. Louis, since July 2004. Ms. Breen is also a member of the Committee of 200 and the New York Women's Forum. She is a David Rockefeller Fellow alumnus and was selected to be among the Academy of Women Achievers in New York. In 2000, Telephony magazine named her as one of the Top Twenty people to watch. She also holds awards from the St. Patrick's Home for the Aging in New York and Irish America Magazine. She is a graduate of Skidmore College and attended executive development programs at Rutgers University and Harvard University.
Donald Burke is the retired head of Blackrock Mutual Funds Division and has been supporting CCFA for more than 20 years. His son was diagnosed with Crohn’s disease at seven-years-old.
Since 2011, Mr. Burke has served as the director of Avista Corporation’s Board of Directors. He currently serves as an independent trustee for the Goldman Sachs mutual fund complex, which consists of a broad range of investment portfolios for retail and institutional investors managed by Goldman Sachs Asset Management, L.P. and certain affiliates. Prior to that, he was a trustee for Blackrock, Inc., and served as Managing Director, President and Chief Executive Officer for Blackrock U.S. Funds from October 2006 to July 2009. For 16 years, Mr. Burke held several positions at Merrill Lynch Investment Managers, including Managing Director, First Vice President, Vice President, Chief Financial Officer and Treasurer, and Director of Taxation. He has a Bachelor’s degree in accounting and economics from the University of Delaware and a Master’s degree in taxation from Pace University.
John Crosson is a member of the Los Angeles chapter board of CCFA and has a personal connection to Crohn’s disease. As a former advertising and marketing executive, he has recently been working with CCFA’s national marketing department on creating a new awareness campaign.
For the past 5 years, Mr. Crosson has worked at Scientific Imaginetics, a start-up medical device company in which Mr. Crosson was an angel investor, CEO, and President. Before deciding to start-up Scientific Imaginetics, Mr. Crosson was an Equity Partner at Crossfire, LLC a closely held private investment company, where he developed, evaluated and made decisions on investment opportunities. Mr. Crosson has also had a notable career in marketing and advertising. He was the President of Grey Advertising in Los Angeles from 1998 to 2005.
Matt Leavitt, D.O., FAOCD
Matt Leavitt, DO, FAOCD has been involved with CCFA for many years and has been the driving force behind crucial development projects of CCFA Orlando. He is the Orlando Take Steps Be Heard Walk Chair and is working to develop a leadership board in the area.
Dr. Leavitt is a Board Certified dermatologist and the Founder and Chief Medical Officer of Advanced Dermatology & Cosmetic Surgery (ADCS). Dr. Leavitt is currently a Clinical Assistant Professor in Dermatology for University of Central Florida, University of Florida, and NOVA Southeastern University. Additionally, he is a preceptor for NOVA University’s Physician Assistant Training Program. A graduate of the University of Michigan and Michigan State University College of Osteopathic Medicine, Dr. Leavitt completed his residency at Ohio University Grandview Medical Center.
Erin Mulvey Stoeber
Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 80 cents of every dollar the Foundation spends going to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance (give.org) and the American Institute of Philanthropy (charitywatch.org).